ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1800

Persistent Fatty Lesions In The Vertebrae In Ankylosing Spondylitis Favor Subsequent New Syndesmophytes: Imaging Results Of a Phase III, Randomized, Placebo-Controlled Study

Kay-Geert A. Hermann1, Xenofon Baraliakos2, Jürgen Braun3, Stephen Xu4 and Benjamin Hsu4, 1Radiology, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 2Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Herne, Germany, 4Janssen Research & Development, LLC., Spring House, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: ankylosing spondylitis (AS) and spine involvement, Biologics, MRI

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: Therapeutics and Outcomes in Spondyloarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

In ankylosing spondylitis (AS), it is hypothesized that stepwise pathologic changes in the spine begin with active inflammation, then fatty degeneration (Fat), leading to syndesmophyte formation.  Using data from the golimumab (GLM) AS study (GO-RAISE), we assessed  how fatty and inflammatory lesions detected by MRI related to subsequent syndesmophytes and bridging on x-ray.

Methods:

In GO-RAISE, 356 patients with definite AS, BASDAI >4, and back pain score >4 were randomized to SC GLM 50mg, 100mg, or PBO q4wks. All patients were to have lateral view radiographs of the cervical and lumbar spine performed at baseline (BL), wks104 and 208. At MRI substudy sites, serial spine MRI scans in the sagittal plane were acquired using 1.5T scanners with T1 and short tau inversion recovery (STIR) sequences at BL, wk14, and wk104 for 98 patients. Two imaging readers blinded to treatment and image order independently evaluated anterior and posterior vertebral corners on x-rays for syndesmophytes/bridging.  Blinded MRI reads were done using ASspiMRI-a scoring of active inflammation (Infl) in vertebral units (VU), with notation of lesional location by VU quadrant (upper, lower x anterior, posterior); and the modified ASspiMRI-c scoring method to assess structural changes including presence of Fat in each of the 23 VU. This analysis focused on percentage of vertebral corners with new syndesmophytes/bridging visible on x-ray at wk 104 and 208, and how this percentage varied by presence or absence of prior Infl or Fat lesions in the corresponding VU quadrants at BL and wk14.

Results:

There were 91 patients in the substudy representing over 1200 VU (cervical, lumbar) with evaluable Fat data by MRI at BL and wk14 and corresponding vertebral corner x-ray data at wk104 and 208.  Of VU with Fat at wk14, more frequently there was also Fat at BL and Fat persisting to wk104, and Infl lesions were more frequently absent at BL than present.  Overall, as assessed by both readers individually and concordantly, the percentage of corners with new syndesmophytes at wk 104 or 208 was greater in VU where Fat was persistently present at both BL and wk14, compared to those where Fat was only present at wk14.  New syndesmophytes were significantly more likely to develop in VU with Fat at both BL and wk14 than those that did not have persistent fat (odds ratios for wk208 syndesmophyte/bridging, Reader 1, 3.27; Reader 2, 2.42).  The combined presence at BL of Fat and Infl lesions in a VU quadrant appeared to further increase the chance of new syndesmophytes developing at the corresponding vertebral corner ([Reader #1] 7.9% and 2.5% of corners with new syndesmophytes at wk104 for VU with BL Fat+Infl/ wk14 Fat  vs. BL Fat-no Infl/ wk14 Fat,  respectively, and [Reader #2] 4.4% and 2.7%, respectively).   Conversely, for VU without Fat or Infl at BL but wk14 Fat present, only 0-1.5% of corners developed new syndesmophytes later.

Conclusion:

This detailed analysis of spine MRI and radiographs at the vertebral level supports the hypothesis that in AS, fatty degeneration and active inflammation within vertebral unit favors progression toward subsequent syndesmophyte growth and ankylosis. 


Disclosure:

K. G. A. Hermann,
None;

X. Baraliakos,

Janssen Research and Development, LLC.,

2;

J. Braun,

Abbott, Bristol-Myers Squibb, Celgene, Celltrion, Chugai, Johnson & Johnson, MSD, Novartis, Pfizer, Roche, UCB Pharma,

2,

Abbott, Bristol-Myers Squibb, Celgene, Celltrion, Chugai, Johnson & Johnson, MSD, Novartis, Pfizer, Roche, UCB Pharma,

5;

S. Xu,

Janssen Research & Development, LLC.,

3;

B. Hsu,

Janssen Research & Development, LLC.,

3.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/persistent-fatty-lesions-in-the-vertebrae-in-ankylosing-spondylitis-favor-subsequent-new-syndesmophytes-imaging-results-of-a-phase-iii-randomized-placebo-controlled-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology